학술논문
Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome
Document Type
Article
Author
Janssen, J.J.W.M.; Ossenkoppele, G.J.; Löwenberg, B.; Jongen-Lavrencic, M.; Manz, M.; Pabst, T.; Gregor, M.; Chalandon, Y.; Heim, D.; Spertini, O.; Stüssi, G.; Biemond, B.J.; Westerweel, P.E.; Klein, S.K.; Fehr, M.; Sinnige, H.A.M.; Efthymiou, A.; Legdeur, M.C.J.C.; van der Poel, M.W.M.; Deeren, D.; Tick, L.W.; van Obbergh, F.; Boersma, R.S.; de Weerdt, O.; van Sluis, G.; Graux, C.; van Norden, Y.
Source
In: Leukemia . (Leukemia, September 2022, 36(9):2189-2195)
Subject
Language
English
ISSN
14765551
08876924
08876924